New Mexico regulators have begun accepting applications from prospective medical psilocybin producers, advancing the state's therapeutic mushroom program closer to launch.
The Medical Psilocybin Program's producer permit application window represents the first opportunity for businesses to enter the state's regulated psychedelic therapy market. State officials said they are prioritizing speed to address patient needs.
"The state is working really hard to operationalize this program as quickly as possible," according to program representatives quoted in Source NM. "People are suffering and they want to address that suffering."
The Framework
New Mexico joins Oregon and Colorado in developing regulated psilocybin programs, though each state has taken a different approach to implementation. Oregon launched its program in 2023, while Colorado voters approved Proposition 122 in 2022.
The producer permits will allow licensed facilities to cultivate psilocybin mushrooms specifically for medical use within the state's therapeutic framework. Applications are separate from the service center permits that will eventually allow supervised administration sessions.
State regulators have not yet announced how many producer licenses they plan to issue or what the application fees will be. The program is being developed under legislation that passed the state legislature earlier this year.
Market Interest
The psychedelic therapy sector has attracted significant investment despite federal Schedule I status. Industry analysts estimate the legal psilocybin market could reach $6.85 billion by 2030 if additional states adopt therapeutic programs.
Several cultivation operations from the cannabis industry have expressed interest in psilocybin production, viewing it as a natural extension of their existing expertise in controlled substance agriculture. The regulatory frameworks share similarities, including security requirements and quality testing protocols.
But psilocybin programs face stricter limitations than medical cannabis. Most state frameworks require supervised administration rather than allowing patients to purchase products for home use.
What's Next
New Mexico has not announced a deadline for the current producer application window or when it expects to begin issuing licenses. Service center applications, which will allow facilities to offer guided psilocybin sessions, remain unopened.
The state must still finalize regulations for testing laboratories, training requirements for facilitators, and patient eligibility criteria before the program can begin serving patients.
Oregon's experience suggests a timeline of 12 to 18 months between opening applications and the first legal psilocybin sessions. That state issued its first producer licenses in mid-2023 and opened its first service centers later that year.
New Mexico regulators have indicated they want to move faster than Oregon's rollout, though they have not committed to specific target dates for program launch.
This article is based on original reporting by www.marijuanamoment.net.
